Pedro A. Valiente

3.8k total citations · 1 hit paper
47 papers, 2.4k citations indexed

About

Pedro A. Valiente is a scholar working on Molecular Biology, Computational Theory and Mathematics and Oncology. According to data from OpenAlex, Pedro A. Valiente has authored 47 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 12 papers in Computational Theory and Mathematics and 10 papers in Oncology. Recurrent topics in Pedro A. Valiente's work include Computational Drug Discovery Methods (12 papers), Protein Structure and Dynamics (11 papers) and Chemical Synthesis and Analysis (7 papers). Pedro A. Valiente is often cited by papers focused on Computational Drug Discovery Methods (12 papers), Protein Structure and Dynamics (11 papers) and Chemical Synthesis and Analysis (7 papers). Pedro A. Valiente collaborates with scholars based in Cuba, Canada and Brazil. Pedro A. Valiente's co-authors include Mario E. Valdés‐Tresanco, Ernesto Moreno, Mario S. Valdés‐Tresanco, Tirso Pons, Philip M. Kim, Pedro G. Pascutti, Uris Ros, María E. Lanio, Sergei Y. Noskov and Carlos Álvarez and has published in prestigious journals such as Bioinformatics, PLoS ONE and Analytical Chemistry.

In The Last Decade

Pedro A. Valiente

44 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS

2021 1.6k citations Mario S. Valdés‐Tresanco, Mario E. Valdés‐Tresanco et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pedro A. Valiente Cuba	16	1.3k	541	406	258	225	47	2.4k
Mario E. Valdés‐Tresanco Cuba	11	1.1k 0.8×	467 0.9×	364 0.9×	241 0.9×	177 0.8×	24	2.1k
Mario S. Valdés‐Tresanco Colombia	8	1.1k 0.8×	464 0.9×	338 0.8×	201 0.8×	181 0.8×	11	2.0k
Kai Zhu United States	18	1.5k 1.1×	622 1.1×	454 1.1×	175 0.7×	227 1.0×	29	2.2k
Abhinav Grover India	33	1.6k 1.2×	672 1.2×	384 0.9×	236 0.9×	461 2.0×	142	2.9k
David L. Pincus United States	10	2.0k 1.6×	496 0.9×	322 0.8×	257 1.0×	200 0.9×	11	3.0k
Natalya S. Bogatyreva Russia	17	1.6k 1.3×	437 0.8×	247 0.6×	173 0.7×	176 0.8×	29	2.4k
David Lagorce France	25	1.4k 1.1×	933 1.7×	361 0.9×	193 0.7×	191 0.8×	34	2.6k
Bill R. Miller United States	11	2.3k 1.8×	739 1.4×	535 1.3×	345 1.3×	382 1.7×	23	3.7k
Sebastian Salentin Germany	13	1.8k 1.4×	851 1.6×	608 1.5×	250 1.0×	275 1.2×	15	3.2k
Andreas Larsson Sweden	21	1.9k 1.5×	312 0.6×	473 1.2×	397 1.5×	131 0.6×	55	2.9k

Countries citing papers authored by Pedro A. Valiente

Since Specialization

Citations

This map shows the geographic impact of Pedro A. Valiente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro A. Valiente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro A. Valiente more than expected).

Fields of papers citing papers by Pedro A. Valiente

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro A. Valiente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro A. Valiente. The network helps show where Pedro A. Valiente may publish in the future.

Co-authorship network of co-authors of Pedro A. Valiente

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro A. Valiente. A scholar is included among the top collaborators of Pedro A. Valiente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro A. Valiente. Pedro A. Valiente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Valiente, Pedro A., Maarten G. Wolf, E. Rudiño-Piñera, et al.. (2025). Discovery of a Noncompetitive Open-Flap Selective Inhibitor of Plasmepsin II with Antiplasmodial Activity. Journal of Chemical Information and Modeling. 65(4). 2038–2051.

Valiente, Pedro A., et al.. (2024). Antibody-SGM, a Score-Based Generative Model for Antibody Heavy-Chain Design. Journal of Chemical Information and Modeling. 64(17). 6745–6757. 2 indexed citations

Malekjahani, Ayden, et al.. (2024). Engineering a Rigid Nucleic Acid Structure to Improve the Limit of Detection for Genetic Assays. Analytical Chemistry. 96(23). 9729–9736. 3 indexed citations

Valiente, Pedro A., et al.. (2024). HelixDiff, a Score-Based Diffusion Model for Generating All-Atom α-Helical Structures. ACS Central Science. 10(5). 1001–1011. 8 indexed citations

Valiente, Pedro A., Satra Nim, Ji‐Sun Kim, & Philip M. Kim. (2023). Computational Design of Potent and Selective d-Peptide Agonists of the Glucagon-like Peptide-2 Receptor. Journal of Medicinal Chemistry. 66(15). 10342–10353. 5 indexed citations

Valdés‐Tresanco, Mario E., Mario S. Valdés‐Tresanco, Ernesto Moreno, & Pedro A. Valiente. (2023). Assessment of Different Parameters on the Accuracy of Computational Alanine Scanning of Protein–Protein Complexes with the Molecular Mechanics/Generalized Born Surface Area Method. The Journal of Physical Chemistry B. 127(4). 944–954. 13 indexed citations

Valiente, Pedro A., et al.. (2023). HelixGAN a deep-learning methodology for conditional de novo design of α-helix structures. Bioinformatics. 39(1). 18 indexed citations

Valiente, Pedro A., et al.. (2023). Three Decades of Targeting Falcipains to Develop AntiplasmodialAgents: What have we Learned and What can be Done Next?. Current Medicinal Chemistry. 31(16). 2234–2263. 2 indexed citations

Valiente, Pedro A., et al.. (2022). Targeting the Receptor-Binding Motif of SARS-CoV-2 with D-Peptides Mimicking the ACE2 Binding Helix: Lessons for Inhibiting Omicron and Future Variants of Concern. Journal of Chemical Information and Modeling. 62(15). 3618–3626. 10 indexed citations

10.

Valiente, Pedro A., et al.. (2020). A Method to Calculate the Relative Binding Free Energy Differences of α-Helical Stapled Peptides. The Journal of Organic Chemistry. 85(3). 1644–1651. 6 indexed citations

11.

Valdés‐Tresanco, Mario S., Mario E. Valdés‐Tresanco, Pedro A. Valiente, & Ernesto Moreno. (2020). AMDock: a versatile graphical tool for assisting molecular docking with Autodock Vina and Autodock4. Biology Direct. 15(1). 12–12. 239 indexed citations

12.

Valiente, Pedro A., et al.. (2019). NMR structure of CmPI-II, a non-classical Kazal protease inhibitor: Understanding its conformational dynamics and subtilisin A inhibition. Journal of Structural Biology. 206(3). 280–294. 7 indexed citations

13.

Rojas, Gertrudis, Tania Carmenate, Pedro A. Valiente, et al.. (2019). Directed evolution of super-secreted variants from phage-displayed human Interleukin-2. Scientific Reports. 9(1). 800–800. 11 indexed citations

14.

Álvarez, Diego E., et al.. (2018). Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures. Biochimica et Biophysica Acta (BBA) - General Subjects. 1862(12). 2911–2923. 12 indexed citations

15.

Méndez, Yanira, Mario E. Valdés‐Tresanco, Pedro A. Valiente, et al.. (2018). Discovery of potent and selective inhibitors of the Escherichia coli M1-aminopeptidase via multicomponent solid-phase synthesis of tetrazole-peptidomimetics. European Journal of Medicinal Chemistry. 163. 481–499. 30 indexed citations

16.

Álvarez, Carlos, Uris Ros, Lohans Pedrera, et al.. (2017). Biophysical and biochemical strategies to understand membrane binding and pore formation by sticholysins, pore-forming proteins from a sea anemone. Biophysical Reviews. 9(5). 529–544. 18 indexed citations

17.

Valiente, Pedro A., Mario E. Valdés‐Tresanco, Lotfi Bounaadja, et al.. (2017). Discovery of novel non-competitive inhibitors of mammalian neutral M1 aminopeptidase (APN). Biochimie. 142. 216–225. 13 indexed citations

18.

Valiente, Pedro A., et al.. (2016). Structures of a bi-functional Kunitz-type STI family inhibitor of serine and aspartic proteases: Could the aspartic protease inhibition have evolved from a canonical serine protease-binding loop?. Journal of Structural Biology. 195(2). 259–271. 9 indexed citations

19.

Gómez, Hansel, et al.. (2014). Dipeptidil peptidasa IV y su implicación en el cáncer. Biotecnología aplicada. 31(2). 102–110. 1 indexed citations

20.

Valiente, Pedro A., et al.. (2011). Predicting functional residues of the Solanum lycopersicum aspartic protease inhibitor (SLAPI) by combining sequence and structural analysis with molecular docking. Journal of Molecular Modeling. 18(6). 2673–2687. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact